FOLH1 and neoplasm: Radiogallium-labeled US2 showed rapid pharmacokinetics; however, its tumor accumulation was less than clinically utilized tumor-imaging probes, such as [68Ga]Ga-PSMA-11 targeting prostate-specific membrane antigen [58].